On 12/24/2024, Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed a series of transactions involving the company's Class A Common Stock. Chi exercised derivative securities, acquiring 17,303 shares at $5.01 per share through a conversion.Immediately following this acquisition, Chi sold an equal number of 17,303 shares in the open market at a price of $27.97 per share. The total market value of the disposed shares amounted to $483,964.91. These transactions were executed on the same day, resulting in no net change to Chi's overall share count.After these transactions, Chi's direct ownership of Hims & Hers Health Class A Common Stock stands at 193,601 shares. The reported transactions have been completed, reflecting a strategic move by the executive to realize gains from the price difference between acquisition and market sale prices.

On 12/24/2024, Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed a series of transactions involving the company's Class A Common Stock. Chi exercised derivative securities, acquiring 17,303 shares at $5.01 per share through a conversion.Immediately following this acquisition, Chi sold an equal number of 17,303 shares in the open market at a price of $27.97 per share. The total market value of the disposed shares amounted to $483,964.91. These transactions were executed on the same day, resulting in no net change to Chi's overall share count.After these transactions, Chi's direct ownership of Hims & Hers Health Class A Common Stock stands at 193,601 shares. The reported transactions have been completed, reflecting a strategic move by the executive to realize gains from the price difference between acquisition and market sale prices.